Back
Albemarle Vs. Denali Therapeutics Industry Stock Comparison
Sell
18
ALB
Albemarle
Last Price:
$88.65
Seasonality Move:
2.79%
Sell
6
DNLI
Denali Therapeutics
Last Price:
$21.48
Seasonality Move:
-13.89%
Sell
6
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy, Sell or Hold?
-
The current Denali Therapeutics [DNLI] share price is $21.46. The Score for DNLI is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ALB Stock Price Chart
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $21.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing slight selling pressure.
ALB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.99 | Sell |
Relative Strength Index (14 RSI): | 32.65 | Sell |
Chaikin Money Flow: | -896798 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (97.19 - 109.83) | Sell |
Bollinger Bands (100): | (85 - 103.78) | Sell |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.18 | Sell |
Relative Strength Index (14 RSI): | 31.49 | Sell |
Chaikin Money Flow: | -592505 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.8 - 25.06) | Sell |
Bollinger Bands (100): | (23.29 - 28.63) | Sell |
ALB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 96.47 | Sell |
20-day SMA: | 102.76 | Sell |
50-day SMA: | 101.18 | Sell |
200-day SMA: | 104.47 | Sell |
8-day EMA: | 95.07 | Sell |
20-day EMA: | 99.75 | Sell |
50-day EMA: | 100.12 | Sell |
200-day EMA: | 108.15 | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.65 | Sell |
20-day SMA: | 23.81 | Sell |
50-day SMA: | 25.85 | Sell |
200-day SMA: | 23.06 | Sell |
8-day EMA: | 22.5 | Sell |
20-day EMA: | 23.71 | Sell |
50-day EMA: | 25.1 | Sell |
200-day EMA: | 24.11 | Sell |
Albemarle Earnings Growth & ALB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, a decrease this year of $23.36 per share, and an increase next year of $2.62 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.84 per share, and a decrease next year of $0.15 per share.
Albemarle Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |